Risk Management



Removal of abnormal cells from eye surface

Removal of abnormal cells from surface of eye consent form can be used when treating OSSN (ocular surface squamous neoplasia) and CIN (conjunctival intraepithelial neoplasia). It is written in plain language to make it easier for patients to understand.

We thank OMIC Director Steven I. Rosenfeld, MD, for his assistance in developing this form.

 

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment



Six reasons OMIC is the best choice for ophthalmologists in America.

Expertise unmatched.

OMIC's sole mission is to serve ophthalmology. The premier source of ophthalmic claims data and loss prevention materials, OMIC's member hotline is the most used ophthalmic consultative service of its kind and OMIC.com is the most visited web site in America for ophthalmic risk management advice and patient consent documents.

61864684